Home/Biophytis/Stanislas Veillet
SV

Stanislas Veillet

Chairman & Chief Executive Officer

Biophytis

Biophytis Pipeline

DrugIndicationPhase
BIO101 (20-hydroxyecdysone)SarcopeniaPhase 3
MASSIVE Project CandidatesSarcopenia (Next-generation)Discovery
AI Platform CandidatesDry Age-Related Macular Degeneration (AMD)Discovery